Skip to content
Brand AI

Glyphic Biotechnologies

Request correction

Corporate brand

Unclaimed

American biotechnology company developing protein sequencing technology.

Last updated September 1, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Glyphic Biotechnologies is an American biotechnology company developing protein sequencing technology. Its technology, ProSE™ (Protein Sequencing by Expansion), aims to enable massively parallel, single-molecule proteome sequencing.

History

Glyphic Biotechnologies is an American biotechnology company developing protein sequencing technology. The company's website describes its ProSE™ technology, which involves sample preparation, molecular expansion, and amino acid sequencing to enable single amino acid discrimination of all 20 amino acids and PTMs.

Products and positioning

  • ProSE™

    Protein Sequencing by Expansion technology for massively parallel, single-molecule proteome sequencing.

Sources2 sources

  1. 1Glyphic Biotechnologies – Next Generation Protein Sequencing Companyglyphic.bio
  2. 2Glyphic Biotechnologieswikidata.org

Cite this profile: Cite the canonical profile. /brand-wiki/glyphic-biotechnologies · Editorial policy · How profiles are compiled